Orthopediatrics Corp (NASDAQ:KIDS) Receives Consensus Rating of “Buy” from Analysts

Share on StockTwits

Orthopediatrics Corp (NASDAQ:KIDS) has received an average rating of “Buy” from the eight brokerages that are covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, six have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 1 year target price among brokers that have updated their coverage on the stock in the last year is $49.67.

KIDS has been the topic of several recent analyst reports. BidaskClub upgraded shares of Orthopediatrics from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, January 1st. SunTrust Banks initiated coverage on shares of Orthopediatrics in a research note on Tuesday, January 7th. They set a “buy” rating and a $54.00 price objective on the stock. Zacks Investment Research upgraded shares of Orthopediatrics from a “hold” rating to a “buy” rating and set a $53.00 price objective on the stock in a research note on Wednesday, January 15th. ValuEngine lowered shares of Orthopediatrics from a “hold” rating to a “sell” rating in a research note on Friday, January 10th. Finally, Piper Jaffray Companies boosted their price objective on shares of Orthopediatrics from $44.00 to $50.00 and gave the stock an “overweight” rating in a research note on Monday, December 16th.

In other news, EVP David R. Bailey sold 15,000 shares of the business’s stock in a transaction dated Friday, December 13th. The shares were sold at an average price of $34.31, for a total transaction of $514,650.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CEO Mark C. Throdahl sold 10,000 shares of the business’s stock in a transaction dated Friday, December 13th. The stock was sold at an average price of $34.31, for a total transaction of $343,100.00. The disclosure for this sale can be found here. 40.70% of the stock is owned by insiders.

Institutional investors and hedge funds have recently made changes to their positions in the stock. US Bancorp DE grew its stake in Orthopediatrics by 9.5% in the 2nd quarter. US Bancorp DE now owns 4,307 shares of the company’s stock valued at $168,000 after buying an additional 375 shares during the last quarter. Oppenheimer Asset Management Inc. grew its stake in Orthopediatrics by 42.6% in the 3rd quarter. Oppenheimer Asset Management Inc. now owns 6,134 shares of the company’s stock valued at $216,000 after buying an additional 1,832 shares during the last quarter. Envestnet Asset Management Inc. acquired a new position in Orthopediatrics in the 3rd quarter valued at about $238,000. Conestoga Capital Advisors LLC grew its stake in Orthopediatrics by 4.1% in the 3rd quarter. Conestoga Capital Advisors LLC now owns 10,820 shares of the company’s stock valued at $382,000 after buying an additional 425 shares during the last quarter. Finally, Signet Financial Management LLC grew its stake in Orthopediatrics by 76.4% in the 4th quarter. Signet Financial Management LLC now owns 11,389 shares of the company’s stock valued at $535,000 after buying an additional 4,931 shares during the last quarter. Institutional investors and hedge funds own 45.54% of the company’s stock.

Shares of NASDAQ:KIDS opened at $47.40 on Wednesday. The company’s 50-day moving average price is $46.04 and its two-hundred day moving average price is $38.24. The company has a debt-to-equity ratio of 0.24, a current ratio of 2.35 and a quick ratio of 1.61. Orthopediatrics has a one year low of $28.19 and a one year high of $51.48. The stock has a market capitalization of $796.50 million, a PE ratio of -62.37 and a beta of 0.28.

Orthopediatrics (NASDAQ:KIDS) last issued its quarterly earnings results on Thursday, November 7th. The company reported ($0.18) EPS for the quarter, missing the consensus estimate of ($0.17) by ($0.01). Orthopediatrics had a negative return on equity of 12.12% and a negative net margin of 15.80%. The business had revenue of $20.74 million for the quarter, compared to the consensus estimate of $19.87 million. During the same period last year, the firm earned ($0.15) earnings per share. The company’s quarterly revenue was up 31.1% compared to the same quarter last year. On average, analysts anticipate that Orthopediatrics will post -0.83 earnings per share for the current fiscal year.

About Orthopediatrics

OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company's products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail products, PediLoc tibia products, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, RESPONSE Spine systems, Bandloc, and Pediguard.

See Also: Outstanding Shares, Buying and Selling Stocks

Analyst Recommendations for Orthopediatrics (NASDAQ:KIDS)

Receive News & Ratings for Orthopediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthopediatrics and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Zacks: Analysts Anticipate Verint Systems Inc.  Will Post Earnings of $1.16 Per Share
Zacks: Analysts Anticipate Verint Systems Inc. Will Post Earnings of $1.16 Per Share
Brokerages Expect Outfront Media Inc  to Post $0.72 Earnings Per Share
Brokerages Expect Outfront Media Inc to Post $0.72 Earnings Per Share
$377.44 Million in Sales Expected for Verint Systems Inc.  This Quarter
$377.44 Million in Sales Expected for Verint Systems Inc. This Quarter
Equitable Financial  and Capitol Federal Financial  Critical Comparison
Equitable Financial and Capitol Federal Financial Critical Comparison
EncryptoTel [WAVES]  Price Up 4.4% Over Last Week
EncryptoTel [WAVES] Price Up 4.4% Over Last Week
BnkToTheFuture Market Cap Hits $11.82 Million
BnkToTheFuture Market Cap Hits $11.82 Million


© 2006-2020 Ticker Report